GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Waypoint Biomedical Holdings Inc (OTCPK:WYPH) » Definitions » 14-Day RSI

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) 14-Day RSI : N/A (As of May. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Waypoint Biomedical Holdings 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-01), Waypoint Biomedical Holdings's 14-Day RSI is N/A.

The industry rank for Waypoint Biomedical Holdings's 14-Day RSI or its related term are showing as below:

WYPH's 14-Day RSI is not ranked *
in the Diversified Financial Services industry.
Industry Median: 54.49
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Waypoint Biomedical Holdings's 14-Day RSI

For the Shell Companies subindustry, Waypoint Biomedical Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waypoint Biomedical Holdings's 14-Day RSI Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Waypoint Biomedical Holdings's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Waypoint Biomedical Holdings's 14-Day RSI falls into.



Waypoint Biomedical Holdings  (OTCPK:WYPH) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waypoint Biomedical Holdings  (OTCPK:WYPH) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Waypoint Biomedical Holdings 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Waypoint Biomedical Holdings's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Waypoint Biomedical Holdings Inc is a shell company.

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Headlines

No Headlines